Industries · Healthcare & Life Sciences
Medical Devices & Diagnostics Legal Recruitment
Device and diagnostics legal hiring runs on FDA premarket and postmarket regulation — now sharply expanded by device-cybersecurity mandates and an enforcement spike. We staff the regulatory, quality, product-liability and compliance counsel that device and diagnostics companies and law firms need, and advise the specialists weighing a confidential move.
FDA-regulated by design — and now under a sharp enforcement squeeze.
Medical device and diagnostics legal hiring centers on FDA premarket and postmarket regulation — 510(k) clearance, PMA approval, De Novo and the Quality System Regulation now transitioning to QMSR — alongside product liability, reimbursement and global regimes, notably the EU MDR and IVDR. That regulatory density is precisely what makes legal and compliance functions mission-critical here rather than back-office.
The framework is dense. The FDA's Center for Devices and Radiological Health (CDRH) governs clearance, approval, quality systems, recalls and consent decrees — and now wields new statutory authority requiring designed-in cybersecurity for connected and software-enabled devices. CMS shapes coverage and reimbursement, including for diagnostics; the EU MDR and IVDR control global market access; and the anti-kickback statute and Sunshine Act govern relationships with clinicians. Diagnostics face additional uncertainty around FDA's approach to laboratory-developed tests. Cybersecurity deficiencies are now a leading driver of both submissions and enforcement.
For in-house teams, that means durable demand for regulatory and product counsel who can operate across FDA, quality-systems and international frameworks simultaneously, plus product-liability, compliance and cybersecurity specialists. Law firms are expanding FDA device-regulatory, product-liability and enforcement-defense practices to match. We recruit on both sides.
For companies hiring legal leaders → For law firms building practices →
An enforcement spike that is reshaping device legal teams.
Two figures frame the moment: a near-doubling of FDA warning letters aimed squarely at device makers, set against the elevated total enforcement activity behind it.
- 47
- FDA warning letters issued to medical-device companies in FY2024 — a 96% increase over the 24 issued in FY2023. The enforcement spike now driving regulatory and quality-counsel hiring across the sub-sector.
- Emergo by UL (analysis of FDA CDRH data), FY2024
- 529
- Total warning letters issued by FDA's CDRH in 2024 (covering devices and radiological-health products), reflecting elevated postmarket enforcement activity — the backdrop against which device legal teams are being deepened.
- Emergo by UL (analysis of FDA CDRH data), 2024
The through-line for buyers: postmarket enforcement is rising fast. A 96% year-over-year jump in warning letters to device companies (Emergo by UL, FY2024) converts regulatory and quality risk directly into hiring demand — for regulatory, quality, enforcement-defense and cybersecurity counsel, at device and diagnostics companies and at the firms that defend them.
The seats that define a device legal function.
From the CDRH regulatory leader who owns the FDA interface to the cybersecurity counsel behind a connected-device mandate, each role maps to a distinct exposure — and to the service that recruits for it.
VP / Head of Regulatory Counsel (CDRH)
The lawyer who owns the FDA/CDRH interface — 510(k), PMA and De Novo pathways, the QSR-to-QMSR transition, recalls and consent decrees. A general-counsel-track regulatory leader we run company-side at device and diagnostics businesses.
In-house counsel recruiting 02Product & Quality Counsel
Counsel embedded with the quality system — labeling, premarket submissions and the design-and-manufacturing controls that decide whether a product clears and stays cleared. The core in-house hire as postmarket enforcement escalates.
In-house counsel recruiting 03Product Liability / Litigation Counsel
Lawyers who manage the implantable- and high-risk-device exposure that turns into product-liability and mass-tort litigation. The seat that absorbs the litigation-heavy reality of device in-house work — and a cycle-resilient bench.
In-house counsel recruiting 04Compliance Counsel (Anti-Kickback, Sunshine Act)
Owners of the fraud-and-abuse and physician-payment-transparency controls that govern device-maker relationships with clinicians. The compliance specialist who keeps commercial practice inside the anti-kickback and Sunshine Act lines.
Compliance recruitment 05Privacy & Cybersecurity Counsel (Connected Devices)
Lawyers for the new statutory device-cybersecurity mandate — designed-in security for connected and software-enabled products, plus the patient-data privacy that rides with them. A fast-growing brief as cybersecurity becomes a leading driver of submission and enforcement activity.
Compliance recruitment 06International Regulatory Counsel (EU MDR / IVDR)
Counsel who build global market access under the EU Medical Device and In-Vitro Diagnostic Regulations — the international regulatory layer that does not transfer cleanly from U.S. FDA practice. The hire behind cross-border launch and conformity.
Legal operations recruitingOn the law-firm side, these map to practice groups in FDA device regulatory (510(k), PMA, De Novo, QMSR), device & software cybersecurity, product liability & mass torts, reimbursement & coverage (incl. diagnostics), EU MDR / IVDR & global market access, fraud & abuse / Sunshine Act compliance, IP & licensing, recalls & enforcement defense. For lateral partner and group hiring, see partner recruiting; for the bench below, see associate recruiting; and where a regulatory or quality need is urgent or interim, see interim legal talent.
The signals that move the headcount.
Enforcement, cybersecurity mandates and the EU transition are expanding the regulatory bench; product-liability exposure and diagnostics reimbursement keep litigation and coverage busy. The honest trade-offs sit at the end — both sides of a search should weigh them.
- i.
Escalating FDA enforcement
The headline driver. CDRH issued 47 warning letters to medical-device companies in FY2024 — a 96% jump over the 24 issued in FY2023 (Emergo by UL, FY2024), against 529 total CDRH warning letters in 2024 (Emergo by UL, 2024). Rising postmarket enforcement converts directly into demand for regulatory, quality and enforcement-defense counsel.
- ii.
Device cybersecurity mandates
New FDA statutory authority requiring designed-in cybersecurity for connected and software-enabled devices generates a fresh stream of regulatory and privacy work. Cybersecurity deficiencies are now a leading driver of submission and enforcement activity — and a fast-growing legal brief.
- iii.
EU MDR / IVDR build-out
The EU Medical Device and In-Vitro Diagnostic Regulations force a global regulatory build-out for any company selling into Europe. International regulatory counsel who can operate across FDA, quality-systems and EU frameworks simultaneously are in durable demand.
- iv.
Product-liability and mass-tort exposure
Implantable and high-risk devices carry sustained product-liability and mass-tort exposure, keeping litigation hiring steady. It also makes device in-house roles litigation-heavy — a reality both sides of a search should weigh.
- v.
Reimbursement complexity for novel diagnostics
Coverage and reimbursement for novel diagnostics and digital-enabled devices — including evolving CMS treatment — adds coverage-counsel demand. Diagnostics also face uncertainty around FDA's approach to laboratory-developed tests, complicating legal-team planning.
- vi.
The trade-off buyers should weigh
The CDRH regulatory skill set is narrow and device-specific — pharma regulatory experience does not transfer cleanly. Diagnostics/LDT oversight is in flux, creating planning uncertainty. Product-liability exposure makes roles litigation-heavy and high-stress, and smaller device and diagnostics companies often lean on outside counsel, concentrating senior in-house seats at larger players. The same specialization is the moat — and the reason the right hire is hard to replace.
The practical takeaway for buyers: hire by FDA pathway and product class, not by title. A pharma regulatory lawyer is not automatically useful in a CDRH 510(k) or PMA fight — and that specificity is exactly what a sector-specialist search is built to map. For compliance and regulatory lawyers weighing a move →
Evidence-led search, mapped by pathway and product class.
In a sub-sector where credibility is device-specific and the right hire is defined by FDA pathway, quality framework and risk profile, generic recruiting misses. We map the field with evidence, then qualify against your specific exposure.
We map real movement
Our market mapping tracks how regulatory, quality, product-liability and cybersecurity counsel actually move across the device and diagnostics companies and firms you compete with — by pathway and product class, so the target list is evidence-led, not whoever is loudest on the market.
We qualify against your exposure
Every approach is tied to your submission pipeline, your postmarket and recall history, your cybersecurity and EU MDR/IVDR footprint and your product-liability profile — not a one-size search. Device-class and pathway fit is qualified up front, not discovered at offer.
Confidential both ways
Candidacy stays blind both ways until a qualified match is confirmed. The market sees a search, not your hiring hand — and the lawyer's current company or firm never learns of the conversation.
It is the same discipline we apply across every mandate — see how our evidence-led methodology works, or the wider Healthcare & Life Sciences practice.
Adjacent legal markets in healthcare — and beyond.
Medical Devices & Diagnostics sits inside a broader Healthcare & Life Sciences practice and connects to the markets next door. Where your mandate spans more than one — a device with a software build, a diagnostics company with a payer dispute — we recruit across the boundary.
Within Healthcare & Life Sciences
Pharmaceuticals
FDA, IP and commercial counsel across the drug lifecycle.
Explore sectorBiotechnology
Counsel for biotech — collaborations, IP and financing.
Explore sectorDigital Health
Lawyers where healthcare regulation meets software.
Explore sectorHospitals & Health Systems
Counsel for providers — fraud and abuse, reimbursement and clinical risk.
Explore sectorManaged Care & Payers
Regulatory and contracting counsel for insurers and PBMs.
Explore sectorRelated markets
Technology, Media & Telecom
Legal leadership for the companies building software, silicon, networks and the platforms the modern economy runs on.
Explore practiceInsurance
Regulatory, claims and transactional counsel for carriers, reinsurers, brokers and insurtech.
Explore practiceSee the full Healthcare & Life Sciences practice, or browse all industries we recruit across.
Hiring in Medical Devices & Diagnostics — common questions
What legal roles are in demand across Medical Devices & Diagnostics right now?
Two streams dominate. On the regulatory side: VP / heads of regulatory counsel (CDRH), product & quality counsel and international regulatory counsel for EU MDR/IVDR — hired against escalating FDA enforcement. On the risk side: product-liability / litigation counsel, compliance counsel for anti-kickback and the Sunshine Act, and a fast-growing seat for privacy & cybersecurity counsel on connected devices. See in-house counsel recruiting and compliance recruitment.
Why is regulatory and quality-counsel hiring rising so sharply?
Enforcement is the defining story. The FDA's CDRH issued 47 warning letters to medical-device companies in FY2024 — a 96% increase over the 24 issued in FY2023 (Emergo by UL, FY2024), within 529 total CDRH warning letters in 2024 covering devices and radiological-health products (Emergo by UL, 2024). Elevated postmarket enforcement, paired with new device-cybersecurity mandates and the EU MDR/IVDR transition, is pushing device and diagnostics companies to deepen their regulatory, quality and compliance benches.
How portable is device regulatory expertise — does pharma experience transfer?
Less than candidates often assume, and it matters to both sides of a search. The CDRH regulatory skill set is narrow and device-specific: 510(k), PMA, De Novo and the QSR-to-QMSR quality framework do not map onto drug-approval practice, so pharma regulatory experience does not transfer cleanly to device work. The same is true of the EU MDR/IVDR layer. That stickiness is the moat — specialist credibility is exactly what makes the right hire hard to replace, which is why we map the field by pathway and product class, not by generic title.
Is diagnostics legal work as stable as devices, given the LDT uncertainty?
Demand is durable but the planning backdrop is in flux. Diagnostics adds the wrinkle of evolving FDA oversight of laboratory-developed tests (LDTs), plus reimbursement and coverage complexity for novel and digital-enabled diagnostics — both of which create planning uncertainty for legal teams. The upside is that this uncertainty itself generates work: companies need counsel who can navigate an unsettled framework and coverage-counsel who can argue reimbursement for new tests. We recruit for that specificity rather than around it.
Why use a sector specialist instead of a generalist recruiter for a device or diagnostics search?
Because the right hire is defined by FDA pathway, product class and risk profile, not a job title. We map real movement across the device and diagnostics companies and firms you compete with, qualify against your specific exposure — your submission pipeline, your postmarket and recall history, your cybersecurity and EU-access footprint — and keep candidacy confidential both ways until a qualified match is confirmed. See how our evidence-led methodology works.
I'm a device or diagnostics lawyer weighing a move — what should I consider?
The sub-sector offers deep, counter-cyclical specialization — FDA regulatory, quality, device cybersecurity, product liability and EU MDR/IVDR all hold value through deal-market downturns because regulation and enforcement continue regardless. The honest caveats: product-liability exposure can make in-house roles litigation-heavy and high-stress, LDT and diagnostics oversight is unsettled, and senior in-house seats concentrate at larger players. The strongest profiles pair CDRH regulatory depth with quality-systems and international fluency. For in-house counsel weighing a move → or explore a confidential move.
Start a confidential conversation
Build the regulatory and quality bench this enforcement market now demands.
Whether you are staffing FDA-regulatory, product, cybersecurity or compliance counsel at a device or diagnostics company, building an FDA device-regulatory or product-liability practice at a firm, or weighing a confidential move yourself — we map the field by pathway and product class and qualify against your exposure. Discreet, sector-specialist, no obligation.